{"database": "lobbying", "table": "lobbying_activities", "rows": [[1696207, "69b673c3-7ceb-41d2-bf35-8b8277f3a00f", "Q2", "CAPITOL HILL STRATEGIES,  LLC", 91774, "BIOGEN INC", 2015, "second_quarter", "CPT", "H.R. 9, Innovation Act (Inter partes review provisions and other provisions relating to patents covered by Hatch-Waxman and Biologics Price Competition and Innovation Act \nS.632, Support Technology and Research for Our Nation's Growth Patents Act of 2015(BPCIA)).", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2015-07-15T12:38:10.917000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1696207"], "units": {}, "query_ms": 2.4280669749714434, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}